Medical Care
Global Biological Indicators Market Research Report 2025
- Apr 07, 25
- ID: 30588
- Pages: 90
- Figures: 90
- Views: 53
The global market for Biological Indicators was valued at US$ 411 million in the year 2024 and is projected to reach a revised size of US$ 610 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.
Biological Indicators (BIs) play a critical role in sterilization validation and infection control, widely used in medical devices, pharmaceuticals, food processing, and life sciences laboratories. They assess the effectiveness of steam, dry heat, ethylene oxide (EO), hydrogen peroxide, and other sterilization methods, ensuring compliance with ISO 11138, USP, and FDA regulations.
Based on form factor, BIs can be categorized into Self-Contained Biological Indicators (SCBIs), BI Strips, and BI Suspensions. Among them, SCBIs are widely used due to their convenience, reduced contamination risk, and enhanced validation efficiency.
In terms of application, the medical sector dominates the market, as hospitals and medical device manufacturers must routinely validate sterilization equipment like autoclaves and plasma sterilizers. The pharmaceutical industry also has stringent requirements for sterilization, especially in injectable drugs, vaccines, and sterile drug production. Additionally, the food and beverage sector is increasingly adopting BIs to monitor sterilization efficiency in processing equipment, ensuring food safety and regulatory compliance.
Regionally, North America is the largest market, with a share nearly 55%. North America and Europe lead the market due to stringent medical regulations and high industry standards. The Asia-Pacific region (especially China and India) is experiencing rapid growth in the BI market, driven by expanding healthcare and pharmaceutical industries and evolving regulatory frameworks. Latin America and the Middle East are also emerging markets, benefiting from improvements in healthcare infrastructure.
Looking ahead, the BI industry is shifting toward more efficient, intelligent, and automated solutions. Rapid-read BIs, electronic BIs (E-BIs), and smart monitoring systems are gradually replacing traditional methods, reducing manual intervention, accelerating sterilization validation, and improving quality control. As pharmaceutical regulations tighten and medical device standards advance, the demand for BIs is expected to rise, ensuring a more reliable approach to sterilization validation and infection control worldwide.
This report aims to provide a comprehensive presentation of the global market for Biological Indicators, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological Indicators.
The Biological Indicators market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biological Indicators market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biological Indicators companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
3M
Getinge Group
Cantel Medical
Mesa Laboratories
Steris
Fuze Medical
Matachana
Hu-Friedy
Advanced Sterilization
Bag Health Care
Terragene
Andersen
GKE
Segment by Type
Self-Contained Biological Indicator
Biological Indicator Strip
Others
Segment by Application
Hospital
Pharma Companies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biological Indicators company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.
Biological Indicators (BIs) play a critical role in sterilization validation and infection control, widely used in medical devices, pharmaceuticals, food processing, and life sciences laboratories. They assess the effectiveness of steam, dry heat, ethylene oxide (EO), hydrogen peroxide, and other sterilization methods, ensuring compliance with ISO 11138, USP, and FDA regulations.
Based on form factor, BIs can be categorized into Self-Contained Biological Indicators (SCBIs), BI Strips, and BI Suspensions. Among them, SCBIs are widely used due to their convenience, reduced contamination risk, and enhanced validation efficiency.
In terms of application, the medical sector dominates the market, as hospitals and medical device manufacturers must routinely validate sterilization equipment like autoclaves and plasma sterilizers. The pharmaceutical industry also has stringent requirements for sterilization, especially in injectable drugs, vaccines, and sterile drug production. Additionally, the food and beverage sector is increasingly adopting BIs to monitor sterilization efficiency in processing equipment, ensuring food safety and regulatory compliance.
Regionally, North America is the largest market, with a share nearly 55%. North America and Europe lead the market due to stringent medical regulations and high industry standards. The Asia-Pacific region (especially China and India) is experiencing rapid growth in the BI market, driven by expanding healthcare and pharmaceutical industries and evolving regulatory frameworks. Latin America and the Middle East are also emerging markets, benefiting from improvements in healthcare infrastructure.
Looking ahead, the BI industry is shifting toward more efficient, intelligent, and automated solutions. Rapid-read BIs, electronic BIs (E-BIs), and smart monitoring systems are gradually replacing traditional methods, reducing manual intervention, accelerating sterilization validation, and improving quality control. As pharmaceutical regulations tighten and medical device standards advance, the demand for BIs is expected to rise, ensuring a more reliable approach to sterilization validation and infection control worldwide.
This report aims to provide a comprehensive presentation of the global market for Biological Indicators, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological Indicators.
The Biological Indicators market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biological Indicators market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biological Indicators companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
3M
Getinge Group
Cantel Medical
Mesa Laboratories
Steris
Fuze Medical
Matachana
Hu-Friedy
Advanced Sterilization
Bag Health Care
Terragene
Andersen
GKE
Segment by Type
Self-Contained Biological Indicator
Biological Indicator Strip
Others
Segment by Application
Hospital
Pharma Companies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biological Indicators company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biological Indicators Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Self-Contained Biological Indicator
1.2.3 Biological Indicator Strip
1.2.4 Others
1.3 Market by Application
1.3.1 Global Biological Indicators Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Pharma Companies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biological Indicators Market Perspective (2020-2031)
2.2 Global Biological Indicators Growth Trends by Region
2.2.1 Global Biological Indicators Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biological Indicators Historic Market Size by Region (2020-2025)
2.2.3 Biological Indicators Forecasted Market Size by Region (2026-2031)
2.3 Biological Indicators Market Dynamics
2.3.1 Biological Indicators Industry Trends
2.3.2 Biological Indicators Market Drivers
2.3.3 Biological Indicators Market Challenges
2.3.4 Biological Indicators Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biological Indicators Players by Revenue
3.1.1 Global Top Biological Indicators Players by Revenue (2020-2025)
3.1.2 Global Biological Indicators Revenue Market Share by Players (2020-2025)
3.2 Global Top Biological Indicators Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biological Indicators Revenue
3.4 Global Biological Indicators Market Concentration Ratio
3.4.1 Global Biological Indicators Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biological Indicators Revenue in 2024
3.5 Global Key Players of Biological Indicators Head office and Area Served
3.6 Global Key Players of Biological Indicators, Product and Application
3.7 Global Key Players of Biological Indicators, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biological Indicators Breakdown Data by Type
4.1 Global Biological Indicators Historic Market Size by Type (2020-2025)
4.2 Global Biological Indicators Forecasted Market Size by Type (2026-2031)
5 Biological Indicators Breakdown Data by Application
5.1 Global Biological Indicators Historic Market Size by Application (2020-2025)
5.2 Global Biological Indicators Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biological Indicators Market Size (2020-2031)
6.2 North America Biological Indicators Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biological Indicators Market Size by Country (2020-2025)
6.4 North America Biological Indicators Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biological Indicators Market Size (2020-2031)
7.2 Europe Biological Indicators Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biological Indicators Market Size by Country (2020-2025)
7.4 Europe Biological Indicators Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biological Indicators Market Size (2020-2031)
8.2 Asia-Pacific Biological Indicators Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biological Indicators Market Size by Region (2020-2025)
8.4 Asia-Pacific Biological Indicators Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biological Indicators Market Size (2020-2031)
9.2 Latin America Biological Indicators Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biological Indicators Market Size by Country (2020-2025)
9.4 Latin America Biological Indicators Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biological Indicators Market Size (2020-2031)
10.2 Middle East & Africa Biological Indicators Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biological Indicators Market Size by Country (2020-2025)
10.4 Middle East & Africa Biological Indicators Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 3M
11.1.1 3M Company Details
11.1.2 3M Business Overview
11.1.3 3M Biological Indicators Introduction
11.1.4 3M Revenue in Biological Indicators Business (2020-2025)
11.1.5 3M Recent Development
11.2 Getinge Group
11.2.1 Getinge Group Company Details
11.2.2 Getinge Group Business Overview
11.2.3 Getinge Group Biological Indicators Introduction
11.2.4 Getinge Group Revenue in Biological Indicators Business (2020-2025)
11.2.5 Getinge Group Recent Development
11.3 Cantel Medical
11.3.1 Cantel Medical Company Details
11.3.2 Cantel Medical Business Overview
11.3.3 Cantel Medical Biological Indicators Introduction
11.3.4 Cantel Medical Revenue in Biological Indicators Business (2020-2025)
11.3.5 Cantel Medical Recent Development
11.4 Mesa Laboratories
11.4.1 Mesa Laboratories Company Details
11.4.2 Mesa Laboratories Business Overview
11.4.3 Mesa Laboratories Biological Indicators Introduction
11.4.4 Mesa Laboratories Revenue in Biological Indicators Business (2020-2025)
11.4.5 Mesa Laboratories Recent Development
11.5 Steris
11.5.1 Steris Company Details
11.5.2 Steris Business Overview
11.5.3 Steris Biological Indicators Introduction
11.5.4 Steris Revenue in Biological Indicators Business (2020-2025)
11.5.5 Steris Recent Development
11.6 Fuze Medical
11.6.1 Fuze Medical Company Details
11.6.2 Fuze Medical Business Overview
11.6.3 Fuze Medical Biological Indicators Introduction
11.6.4 Fuze Medical Revenue in Biological Indicators Business (2020-2025)
11.6.5 Fuze Medical Recent Development
11.7 Matachana
11.7.1 Matachana Company Details
11.7.2 Matachana Business Overview
11.7.3 Matachana Biological Indicators Introduction
11.7.4 Matachana Revenue in Biological Indicators Business (2020-2025)
11.7.5 Matachana Recent Development
11.8 Hu-Friedy
11.8.1 Hu-Friedy Company Details
11.8.2 Hu-Friedy Business Overview
11.8.3 Hu-Friedy Biological Indicators Introduction
11.8.4 Hu-Friedy Revenue in Biological Indicators Business (2020-2025)
11.8.5 Hu-Friedy Recent Development
11.9 Advanced Sterilization
11.9.1 Advanced Sterilization Company Details
11.9.2 Advanced Sterilization Business Overview
11.9.3 Advanced Sterilization Biological Indicators Introduction
11.9.4 Advanced Sterilization Revenue in Biological Indicators Business (2020-2025)
11.9.5 Advanced Sterilization Recent Development
11.10 Bag Health Care
11.10.1 Bag Health Care Company Details
11.10.2 Bag Health Care Business Overview
11.10.3 Bag Health Care Biological Indicators Introduction
11.10.4 Bag Health Care Revenue in Biological Indicators Business (2020-2025)
11.10.5 Bag Health Care Recent Development
11.11 Terragene
11.11.1 Terragene Company Details
11.11.2 Terragene Business Overview
11.11.3 Terragene Biological Indicators Introduction
11.11.4 Terragene Revenue in Biological Indicators Business (2020-2025)
11.11.5 Terragene Recent Development
11.12 Andersen
11.12.1 Andersen Company Details
11.12.2 Andersen Business Overview
11.12.3 Andersen Biological Indicators Introduction
11.12.4 Andersen Revenue in Biological Indicators Business (2020-2025)
11.12.5 Andersen Recent Development
11.13 GKE
11.13.1 GKE Company Details
11.13.2 GKE Business Overview
11.13.3 GKE Biological Indicators Introduction
11.13.4 GKE Revenue in Biological Indicators Business (2020-2025)
11.13.5 GKE Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biological Indicators Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Self-Contained Biological Indicator
1.2.3 Biological Indicator Strip
1.2.4 Others
1.3 Market by Application
1.3.1 Global Biological Indicators Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Pharma Companies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biological Indicators Market Perspective (2020-2031)
2.2 Global Biological Indicators Growth Trends by Region
2.2.1 Global Biological Indicators Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biological Indicators Historic Market Size by Region (2020-2025)
2.2.3 Biological Indicators Forecasted Market Size by Region (2026-2031)
2.3 Biological Indicators Market Dynamics
2.3.1 Biological Indicators Industry Trends
2.3.2 Biological Indicators Market Drivers
2.3.3 Biological Indicators Market Challenges
2.3.4 Biological Indicators Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biological Indicators Players by Revenue
3.1.1 Global Top Biological Indicators Players by Revenue (2020-2025)
3.1.2 Global Biological Indicators Revenue Market Share by Players (2020-2025)
3.2 Global Top Biological Indicators Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biological Indicators Revenue
3.4 Global Biological Indicators Market Concentration Ratio
3.4.1 Global Biological Indicators Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biological Indicators Revenue in 2024
3.5 Global Key Players of Biological Indicators Head office and Area Served
3.6 Global Key Players of Biological Indicators, Product and Application
3.7 Global Key Players of Biological Indicators, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biological Indicators Breakdown Data by Type
4.1 Global Biological Indicators Historic Market Size by Type (2020-2025)
4.2 Global Biological Indicators Forecasted Market Size by Type (2026-2031)
5 Biological Indicators Breakdown Data by Application
5.1 Global Biological Indicators Historic Market Size by Application (2020-2025)
5.2 Global Biological Indicators Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biological Indicators Market Size (2020-2031)
6.2 North America Biological Indicators Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biological Indicators Market Size by Country (2020-2025)
6.4 North America Biological Indicators Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biological Indicators Market Size (2020-2031)
7.2 Europe Biological Indicators Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biological Indicators Market Size by Country (2020-2025)
7.4 Europe Biological Indicators Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biological Indicators Market Size (2020-2031)
8.2 Asia-Pacific Biological Indicators Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biological Indicators Market Size by Region (2020-2025)
8.4 Asia-Pacific Biological Indicators Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biological Indicators Market Size (2020-2031)
9.2 Latin America Biological Indicators Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biological Indicators Market Size by Country (2020-2025)
9.4 Latin America Biological Indicators Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biological Indicators Market Size (2020-2031)
10.2 Middle East & Africa Biological Indicators Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biological Indicators Market Size by Country (2020-2025)
10.4 Middle East & Africa Biological Indicators Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 3M
11.1.1 3M Company Details
11.1.2 3M Business Overview
11.1.3 3M Biological Indicators Introduction
11.1.4 3M Revenue in Biological Indicators Business (2020-2025)
11.1.5 3M Recent Development
11.2 Getinge Group
11.2.1 Getinge Group Company Details
11.2.2 Getinge Group Business Overview
11.2.3 Getinge Group Biological Indicators Introduction
11.2.4 Getinge Group Revenue in Biological Indicators Business (2020-2025)
11.2.5 Getinge Group Recent Development
11.3 Cantel Medical
11.3.1 Cantel Medical Company Details
11.3.2 Cantel Medical Business Overview
11.3.3 Cantel Medical Biological Indicators Introduction
11.3.4 Cantel Medical Revenue in Biological Indicators Business (2020-2025)
11.3.5 Cantel Medical Recent Development
11.4 Mesa Laboratories
11.4.1 Mesa Laboratories Company Details
11.4.2 Mesa Laboratories Business Overview
11.4.3 Mesa Laboratories Biological Indicators Introduction
11.4.4 Mesa Laboratories Revenue in Biological Indicators Business (2020-2025)
11.4.5 Mesa Laboratories Recent Development
11.5 Steris
11.5.1 Steris Company Details
11.5.2 Steris Business Overview
11.5.3 Steris Biological Indicators Introduction
11.5.4 Steris Revenue in Biological Indicators Business (2020-2025)
11.5.5 Steris Recent Development
11.6 Fuze Medical
11.6.1 Fuze Medical Company Details
11.6.2 Fuze Medical Business Overview
11.6.3 Fuze Medical Biological Indicators Introduction
11.6.4 Fuze Medical Revenue in Biological Indicators Business (2020-2025)
11.6.5 Fuze Medical Recent Development
11.7 Matachana
11.7.1 Matachana Company Details
11.7.2 Matachana Business Overview
11.7.3 Matachana Biological Indicators Introduction
11.7.4 Matachana Revenue in Biological Indicators Business (2020-2025)
11.7.5 Matachana Recent Development
11.8 Hu-Friedy
11.8.1 Hu-Friedy Company Details
11.8.2 Hu-Friedy Business Overview
11.8.3 Hu-Friedy Biological Indicators Introduction
11.8.4 Hu-Friedy Revenue in Biological Indicators Business (2020-2025)
11.8.5 Hu-Friedy Recent Development
11.9 Advanced Sterilization
11.9.1 Advanced Sterilization Company Details
11.9.2 Advanced Sterilization Business Overview
11.9.3 Advanced Sterilization Biological Indicators Introduction
11.9.4 Advanced Sterilization Revenue in Biological Indicators Business (2020-2025)
11.9.5 Advanced Sterilization Recent Development
11.10 Bag Health Care
11.10.1 Bag Health Care Company Details
11.10.2 Bag Health Care Business Overview
11.10.3 Bag Health Care Biological Indicators Introduction
11.10.4 Bag Health Care Revenue in Biological Indicators Business (2020-2025)
11.10.5 Bag Health Care Recent Development
11.11 Terragene
11.11.1 Terragene Company Details
11.11.2 Terragene Business Overview
11.11.3 Terragene Biological Indicators Introduction
11.11.4 Terragene Revenue in Biological Indicators Business (2020-2025)
11.11.5 Terragene Recent Development
11.12 Andersen
11.12.1 Andersen Company Details
11.12.2 Andersen Business Overview
11.12.3 Andersen Biological Indicators Introduction
11.12.4 Andersen Revenue in Biological Indicators Business (2020-2025)
11.12.5 Andersen Recent Development
11.13 GKE
11.13.1 GKE Company Details
11.13.2 GKE Business Overview
11.13.3 GKE Biological Indicators Introduction
11.13.4 GKE Revenue in Biological Indicators Business (2020-2025)
11.13.5 GKE Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Biological Indicators Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Self-Contained Biological Indicator
Table 3. Key Players of Biological Indicator Strip
Table 4. Key Players of Others
Table 5. Global Biological Indicators Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Biological Indicators Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Biological Indicators Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Biological Indicators Market Share by Region (2020-2025)
Table 9. Global Biological Indicators Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Biological Indicators Market Share by Region (2026-2031)
Table 11. Biological Indicators Market Trends
Table 12. Biological Indicators Market Drivers
Table 13. Biological Indicators Market Challenges
Table 14. Biological Indicators Market Restraints
Table 15. Global Biological Indicators Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Biological Indicators Market Share by Players (2020-2025)
Table 17. Global Top Biological Indicators Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Indicators as of 2024)
Table 18. Ranking of Global Top Biological Indicators Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Biological Indicators Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Biological Indicators, Headquarters and Area Served
Table 21. Global Key Players of Biological Indicators, Product and Application
Table 22. Global Key Players of Biological Indicators, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biological Indicators Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Biological Indicators Revenue Market Share by Type (2020-2025)
Table 26. Global Biological Indicators Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Biological Indicators Revenue Market Share by Type (2026-2031)
Table 28. Global Biological Indicators Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Biological Indicators Revenue Market Share by Application (2020-2025)
Table 30. Global Biological Indicators Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Biological Indicators Revenue Market Share by Application (2026-2031)
Table 32. North America Biological Indicators Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Biological Indicators Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Biological Indicators Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Biological Indicators Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Biological Indicators Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Biological Indicators Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Biological Indicators Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Biological Indicators Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Biological Indicators Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Biological Indicators Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Biological Indicators Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Biological Indicators Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Biological Indicators Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Biological Indicators Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Biological Indicators Market Size by Country (2026-2031) & (US$ Million)
Table 47. 3M Company Details
Table 48. 3M Business Overview
Table 49. 3M Biological Indicators Product
Table 50. 3M Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 51. 3M Recent Development
Table 52. Getinge Group Company Details
Table 53. Getinge Group Business Overview
Table 54. Getinge Group Biological Indicators Product
Table 55. Getinge Group Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 56. Getinge Group Recent Development
Table 57. Cantel Medical Company Details
Table 58. Cantel Medical Business Overview
Table 59. Cantel Medical Biological Indicators Product
Table 60. Cantel Medical Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 61. Cantel Medical Recent Development
Table 62. Mesa Laboratories Company Details
Table 63. Mesa Laboratories Business Overview
Table 64. Mesa Laboratories Biological Indicators Product
Table 65. Mesa Laboratories Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 66. Mesa Laboratories Recent Development
Table 67. Steris Company Details
Table 68. Steris Business Overview
Table 69. Steris Biological Indicators Product
Table 70. Steris Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 71. Steris Recent Development
Table 72. Fuze Medical Company Details
Table 73. Fuze Medical Business Overview
Table 74. Fuze Medical Biological Indicators Product
Table 75. Fuze Medical Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 76. Fuze Medical Recent Development
Table 77. Matachana Company Details
Table 78. Matachana Business Overview
Table 79. Matachana Biological Indicators Product
Table 80. Matachana Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 81. Matachana Recent Development
Table 82. Hu-Friedy Company Details
Table 83. Hu-Friedy Business Overview
Table 84. Hu-Friedy Biological Indicators Product
Table 85. Hu-Friedy Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 86. Hu-Friedy Recent Development
Table 87. Advanced Sterilization Company Details
Table 88. Advanced Sterilization Business Overview
Table 89. Advanced Sterilization Biological Indicators Product
Table 90. Advanced Sterilization Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 91. Advanced Sterilization Recent Development
Table 92. Bag Health Care Company Details
Table 93. Bag Health Care Business Overview
Table 94. Bag Health Care Biological Indicators Product
Table 95. Bag Health Care Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 96. Bag Health Care Recent Development
Table 97. Terragene Company Details
Table 98. Terragene Business Overview
Table 99. Terragene Biological Indicators Product
Table 100. Terragene Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 101. Terragene Recent Development
Table 102. Andersen Company Details
Table 103. Andersen Business Overview
Table 104. Andersen Biological Indicators Product
Table 105. Andersen Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 106. Andersen Recent Development
Table 107. GKE Company Details
Table 108. GKE Business Overview
Table 109. GKE Biological Indicators Product
Table 110. GKE Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 111. GKE Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
Table 115. Authors List of This Report
List of Figures
Figure 1. Biological Indicators Picture
Figure 2. Global Biological Indicators Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biological Indicators Market Share by Type: 2024 VS 2031
Figure 4. Self-Contained Biological Indicator Features
Figure 5. Biological Indicator Strip Features
Figure 6. Others Features
Figure 7. Global Biological Indicators Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Biological Indicators Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Pharma Companies Case Studies
Figure 11. Others Case Studies
Figure 12. Biological Indicators Report Years Considered
Figure 13. Global Biological Indicators Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Biological Indicators Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Biological Indicators Market Share by Region: 2024 VS 2031
Figure 16. Global Biological Indicators Market Share by Players in 2024
Figure 17. Global Biological Indicators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Biological Indicators Revenue in 2024
Figure 19. North America Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Biological Indicators Market Share by Country (2020-2031)
Figure 21. United States Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Biological Indicators Market Share by Country (2020-2031)
Figure 25. Germany Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Biological Indicators Market Share by Region (2020-2031)
Figure 33. China Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Biological Indicators Market Share by Country (2020-2031)
Figure 41. Mexico Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Biological Indicators Market Share by Country (2020-2031)
Figure 45. Turkey Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. 3M Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 49. Getinge Group Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 50. Cantel Medical Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 51. Mesa Laboratories Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 52. Steris Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 53. Fuze Medical Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 54. Matachana Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 55. Hu-Friedy Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 56. Advanced Sterilization Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 57. Bag Health Care Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 58. Terragene Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 59. Andersen Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 60. GKE Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Biological Indicators Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Self-Contained Biological Indicator
Table 3. Key Players of Biological Indicator Strip
Table 4. Key Players of Others
Table 5. Global Biological Indicators Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Biological Indicators Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Biological Indicators Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Biological Indicators Market Share by Region (2020-2025)
Table 9. Global Biological Indicators Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Biological Indicators Market Share by Region (2026-2031)
Table 11. Biological Indicators Market Trends
Table 12. Biological Indicators Market Drivers
Table 13. Biological Indicators Market Challenges
Table 14. Biological Indicators Market Restraints
Table 15. Global Biological Indicators Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Biological Indicators Market Share by Players (2020-2025)
Table 17. Global Top Biological Indicators Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Indicators as of 2024)
Table 18. Ranking of Global Top Biological Indicators Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Biological Indicators Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Biological Indicators, Headquarters and Area Served
Table 21. Global Key Players of Biological Indicators, Product and Application
Table 22. Global Key Players of Biological Indicators, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biological Indicators Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Biological Indicators Revenue Market Share by Type (2020-2025)
Table 26. Global Biological Indicators Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Biological Indicators Revenue Market Share by Type (2026-2031)
Table 28. Global Biological Indicators Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Biological Indicators Revenue Market Share by Application (2020-2025)
Table 30. Global Biological Indicators Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Biological Indicators Revenue Market Share by Application (2026-2031)
Table 32. North America Biological Indicators Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Biological Indicators Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Biological Indicators Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Biological Indicators Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Biological Indicators Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Biological Indicators Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Biological Indicators Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Biological Indicators Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Biological Indicators Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Biological Indicators Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Biological Indicators Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Biological Indicators Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Biological Indicators Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Biological Indicators Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Biological Indicators Market Size by Country (2026-2031) & (US$ Million)
Table 47. 3M Company Details
Table 48. 3M Business Overview
Table 49. 3M Biological Indicators Product
Table 50. 3M Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 51. 3M Recent Development
Table 52. Getinge Group Company Details
Table 53. Getinge Group Business Overview
Table 54. Getinge Group Biological Indicators Product
Table 55. Getinge Group Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 56. Getinge Group Recent Development
Table 57. Cantel Medical Company Details
Table 58. Cantel Medical Business Overview
Table 59. Cantel Medical Biological Indicators Product
Table 60. Cantel Medical Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 61. Cantel Medical Recent Development
Table 62. Mesa Laboratories Company Details
Table 63. Mesa Laboratories Business Overview
Table 64. Mesa Laboratories Biological Indicators Product
Table 65. Mesa Laboratories Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 66. Mesa Laboratories Recent Development
Table 67. Steris Company Details
Table 68. Steris Business Overview
Table 69. Steris Biological Indicators Product
Table 70. Steris Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 71. Steris Recent Development
Table 72. Fuze Medical Company Details
Table 73. Fuze Medical Business Overview
Table 74. Fuze Medical Biological Indicators Product
Table 75. Fuze Medical Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 76. Fuze Medical Recent Development
Table 77. Matachana Company Details
Table 78. Matachana Business Overview
Table 79. Matachana Biological Indicators Product
Table 80. Matachana Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 81. Matachana Recent Development
Table 82. Hu-Friedy Company Details
Table 83. Hu-Friedy Business Overview
Table 84. Hu-Friedy Biological Indicators Product
Table 85. Hu-Friedy Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 86. Hu-Friedy Recent Development
Table 87. Advanced Sterilization Company Details
Table 88. Advanced Sterilization Business Overview
Table 89. Advanced Sterilization Biological Indicators Product
Table 90. Advanced Sterilization Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 91. Advanced Sterilization Recent Development
Table 92. Bag Health Care Company Details
Table 93. Bag Health Care Business Overview
Table 94. Bag Health Care Biological Indicators Product
Table 95. Bag Health Care Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 96. Bag Health Care Recent Development
Table 97. Terragene Company Details
Table 98. Terragene Business Overview
Table 99. Terragene Biological Indicators Product
Table 100. Terragene Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 101. Terragene Recent Development
Table 102. Andersen Company Details
Table 103. Andersen Business Overview
Table 104. Andersen Biological Indicators Product
Table 105. Andersen Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 106. Andersen Recent Development
Table 107. GKE Company Details
Table 108. GKE Business Overview
Table 109. GKE Biological Indicators Product
Table 110. GKE Revenue in Biological Indicators Business (2020-2025) & (US$ Million)
Table 111. GKE Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
Table 115. Authors List of This Report
List of Figures
Figure 1. Biological Indicators Picture
Figure 2. Global Biological Indicators Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biological Indicators Market Share by Type: 2024 VS 2031
Figure 4. Self-Contained Biological Indicator Features
Figure 5. Biological Indicator Strip Features
Figure 6. Others Features
Figure 7. Global Biological Indicators Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Biological Indicators Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Pharma Companies Case Studies
Figure 11. Others Case Studies
Figure 12. Biological Indicators Report Years Considered
Figure 13. Global Biological Indicators Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Biological Indicators Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Biological Indicators Market Share by Region: 2024 VS 2031
Figure 16. Global Biological Indicators Market Share by Players in 2024
Figure 17. Global Biological Indicators Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Biological Indicators Revenue in 2024
Figure 19. North America Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Biological Indicators Market Share by Country (2020-2031)
Figure 21. United States Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Biological Indicators Market Share by Country (2020-2031)
Figure 25. Germany Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Biological Indicators Market Share by Region (2020-2031)
Figure 33. China Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Biological Indicators Market Share by Country (2020-2031)
Figure 41. Mexico Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Biological Indicators Market Share by Country (2020-2031)
Figure 45. Turkey Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Biological Indicators Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. 3M Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 49. Getinge Group Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 50. Cantel Medical Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 51. Mesa Laboratories Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 52. Steris Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 53. Fuze Medical Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 54. Matachana Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 55. Hu-Friedy Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 56. Advanced Sterilization Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 57. Bag Health Care Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 58. Terragene Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 59. Andersen Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 60. GKE Revenue Growth Rate in Biological Indicators Business (2020-2025)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232